Publication date: Available online 13 July 2018
Source: Trends in Endocrinology & Metabolism
Author(s): Almudena Veiga-Lopez, Yong Pu, Jeremy Gingrich, Vasantha Padmanabhan
Endocrine disrupting chemicals (EDCs) are compounds that are part of everyday consumer products and industrial manufacturing processes. EDCs can interfere with the endocrine system, including the adipose tissue. Accumulating evidence from epidemiological, animal, and in vitro studies demonstrates that EDCs can alter body weight, adipose tissue expansion, circulating lipid profile, and adipogenesis, with some resulting in transgenerational effects. These outcomes appear to be mediated through multiple mechanisms, from nuclear receptor binding to epigenetic modifications. A better understanding of the signaling pathways via which these EDCs contribute to an obesogenic phenotype, the interaction amongst complex mixtures of obesogenic EDCs, and the risks they pose relative to the obesity epidemic are still needed for risk assessment and development of prevention strategies.
https://ift.tt/2L5M8nz
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου